Markforged FY 2021 revenue grows by 27%, to .2 million Money & Funding

Markforged FY 2021 Revenue Grows by 27%, to $91.2 Million

Markforged Holding Corporation reported that its revenues increased 27%, to $91.2 million, in FY 2021, from $71.9 million in 2020. Gross profit grew 26%, to $52.9 million, in 2021 from $41.9 million in 2020 and gross margin was 58% in 2021, consistent with 2020. However net loss from operations also grew during the Markforged FY 2021, to $61.0 million (compared to a net loss from operations of $17.7 million in the year prior). Quarterly (Q4) revenues also grew. The result is even more significant as the company generated almost as much revenue as its competitor Dekstop Metal did after acquiring two large AM companies (and several smaller ones).

Nanoscribe and CELLINK Join Forces to Release Quantum X Bio 2PP Bioprinter

Nanoscribe and CELLINK Join Forces to Release Quantum X Bio 2PP Bioprinter

Nanoscribe and CELLINK, two BICO companies, today jointly unveiled the Quantum X bio, a revolutionary system as part of the Nanoscribe Quantum X platform providing researchers with a very accurate 3D bioprinter. The Quantum X bio is the first-of-its-kind bioprinter enabling submicron printing resolution. Powered by Two-Photon Polymerization (2PP), the Quantum X bio is the premier tool for miniaturizing bioprinting to redefine the development of complex tissue or cell scaffolds and of advanced biomedical applications.

Incus Closes Series A Investment Round

Incus Closes Series A Investment Round

Incus GmbH, an Austrian 3D-printing manufacturer specialized in Lithography-based Metal Manufacturing (LMM), closed a Series A investment round in Q4 2021, also including existing investor AM Ventures. The company is also bringing onboard industry veteran Adrian Keppler, former CEO of world market leader in Powder Bed Fusion systems EOS GmbH, as an investor and growth consultant.

Bioprinting Company REGEMAT3D to Open Equity crowd funding round 3D Printer Hardware

Bioprinting Company REGEMAT3D to Open Equity Crowd Funding Round

Bioprinter manufacturer REGEMAT3D is launching a new equity crowdfunding round, that will help the company further scale its business and product lines while preparing for an IPO set to take place in 2023. At 3dpbm we usually do not cover crowdfunding campaigns for new products, however, this initiative is relative to a company that is already present in the market and has been making significant progress in the bioprinting segment. REGEMAT3D promises massive returns (up to 3 to 4 times the investment) and while the actual success of this financial initiative is subject to the same risks as any financial venture, the overall bioprinting segment is in fact growing up rapidly.

Wacker Chemie to Shut Down ACEO Silicone 3D Printing Service

Wacker Chemie to Shut Down ACEO Silicone 3D Printing Service

ACEO (aka ACEO3D), the silicone 3D printing service based of German silicone giant Wacker Chemie, is shutting down at the end of 2021. The company took orders until December 10th and from now on will only work on projects on a case-by-case basis. While introducing a unique technology with unparalleled silicone 3D printing capabilities, unfortunately, ACEO3D also provided a perfect case to show what not to do when marketing such an innovative and potentially revolutionary product.